Apolipoprotein L1 Gene Testing Comes of Age.
作者信息
Freedman Barry I, Larsen Chris P
机构信息
Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina; and.
Arkana Laboratories, Little Rock, Arkansas.
出版信息
Kidney360. 2020 Jan 8;1(1):58-61. doi: 10.34067/KID.0000162019. eCollection 2020 Jan 30.
Abstract
摘要
相似文献
1
Apolipoprotein L1 Gene Testing Comes of Age.载脂蛋白L1基因检测走向成熟。
Kidney360. 2020 Jan 8;1(1):58-61. doi: 10.34067/KID.0000162019. eCollection 2020 Jan 30.
2
Transplant Nephrologists' Preferences for Clinical Decision Support for APOL1 Genetic Testing of Living Kidney Donors: A Focus Group Study.移植肾脏病专家对活体肾脏供者 APOL1 基因检测的临床决策支持的偏好：一项焦点小组研究。
Kidney360. 2023 Nov 1;4(11):1610-1614. doi: 10.34067/KID.0000000000000265. Epub 2023 Oct 12.
3
Apolipoprotein L1 and apolipoprotein A-IV and their association with kidney function.载脂蛋白L1和载脂蛋白A-IV及其与肾功能的关联。
Curr Opin Lipidol. 2017 Feb;28(1):39-45. doi: 10.1097/MOL.0000000000000371.
4
Apolipoprotein L1 nephropathies: 2017 in review.载脂蛋白 L1 肾病：2017 年回顾。
Curr Opin Nephrol Hypertens. 2018 May;27(3):153-158. doi: 10.1097/MNH.0000000000000399.
5
Apolipoprotein L1 and kidney transplantation.载脂蛋白 L1 与肾移植。
Curr Opin Organ Transplant. 2019 Feb;24(1):97-102. doi: 10.1097/MOT.0000000000000600.
6
Recipient APOL1 Genotype Effects on Outcomes After Kidney Transplantation.肾移植受者APOL1基因型对移植后结局的影响。
Am J Kidney Dis. 2022 Mar;79(3):450-452. doi: 10.1053/j.ajkd.2021.11.001. Epub 2021 Nov 18.
7
APOL1 genotyping in kidney transplantation: a look into the future.肾移植中的载脂蛋白L1基因分型：展望未来。
Kidney Int. 2021 Jul;100(1):32-34. doi: 10.1016/j.kint.2021.03.030.
8
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).肾脏移植中的载脂蛋白L1基因分型：做还是不做，这是个问题？（反对意见）
Kidney Int. 2021 Jul;100(1):30-32. doi: 10.1016/j.kint.2021.02.041.
9
APOL1 high-risk genotypes and renal transplantation.APOL1 高危基因型与肾移植。
Clin Transplant. 2019 Jun;33(6):e13582. doi: 10.1111/ctr.13582. Epub 2019 May 24.
10
APOL1: a case in point for replacing race with genetics.APOL1：用遗传学取代种族的一个典型例子。
Kidney Int. 2017 Apr;91(4):768-770. doi: 10.1016/j.kint.2017.02.002.
引用本文的文献
1
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.载脂蛋白-L1 G1变体在载脂蛋白E基因敲除小鼠中导致脑积水，但不导致动脉粥样硬化。
Clin Sci (Lond). 2025 May 27. doi: 10.1042/CS20255324.
2
High-Fidelity CRISPR-Cas12a-Based Apolipoprotein L1 Genotyping.基于高保真CRISPR-Cas12a的载脂蛋白L1基因分型
Kidney360. 2025 May 28;6(7):1207-1217. doi: 10.34067/KID.0000000871.
3
Apolipoprotein-L1 G1 variant contributes to hydrocephalus but not to atherosclerosis in apolipoprotein-E knock-out mice.载脂蛋白L1 G1变体在载脂蛋白E基因敲除小鼠中导致脑积水，但不导致动脉粥样硬化。
bioRxiv. 2024 Dec 28:2024.12.28.630625. doi: 10.1101/2024.12.28.630625.
4
Single-Cell Transcriptional Signatures of Glomerular Disease in Transgenic Mice with APOL1 Variants.APOL1 变异转基因小鼠肾小球疾病的单细胞转录特征。
J Am Soc Nephrol. 2024 Aug 1;35(8):1058-1075. doi: 10.1681/ASN.0000000000000370. Epub 2024 May 6.
5
Risk Variants and Acute Kidney Injury in Black Americans with COVID-19.美国黑人 COVID-19 患者的风险变异与急性肾损伤。
Clin J Am Soc Nephrol. 2021 Dec;16(12):1790-1796. doi: 10.2215/CJN.01070121.
6
APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).肾移植中的载脂蛋白L1基因分型：做还是不做，这是个问题？（正方观点）
Kidney Int. 2021 Jul;100(1):27-30. doi: 10.1016/j.kint.2020.11.025.
本文引用的文献
1
APOL1 Kidney Risk Variants Induce Cell Death Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.APOL1 肾脏风险变异诱导细胞死亡、线粒体易位和线粒体通透性转换孔开放。
J Am Soc Nephrol. 2019 Dec;30(12):2355-2368. doi: 10.1681/ASN.2019020114. Epub 2019 Sep 26.
2
Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.肾脏风险变异与心血管疾病：一项个体参与者数据荟萃分析。
J Am Soc Nephrol. 2019 Oct;30(10):2027-2036. doi: 10.1681/ASN.2019030240. Epub 2019 Aug 5.
3
Association of Risk Alleles With Cardiovascular Disease in Blacks in the Million Veteran Program.百万退伍军人计划中黑人的风险等位基因与心血管疾病的关联。
Circulation. 2019 Sep 17;140(12):1031-1040. doi: 10.1161/CIRCULATIONAHA.118.036589. Epub 2019 Jul 24.
4
Antisense oligonucleotide treatment ameliorates IFN-γ-induced proteinuria in APOL1-transgenic mice.反义寡核苷酸治疗可改善 APOL1 转基因小鼠 IFN-γ 诱导的蛋白尿。
JCI Insight. 2019 Jun 20;4(12). doi: 10.1172/jci.insight.126124.
5
You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.你现在才告诉我们这件事？非裔美国人对肾脏疾病遗传易感性检测的看法。
J Am Soc Nephrol. 2019 Apr;30(4):526-530. doi: 10.1681/ASN.2018111091. Epub 2019 Mar 11.
6
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.APOL1 相关肾病：慢性肾脏病中导致种族差异的关键因素。
Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S8-S16. doi: 10.1053/j.ajkd.2018.06.020.
7
The Long-Term Kidney Transplantation Outcomes Network-APOLLO.长期肾移植结局网络-阿波罗计划
Clin J Am Soc Nephrol. 2018 Jun 7;13(6):940-942. doi: 10.2215/CJN.01510218. Epub 2018 Apr 27.
8
Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants.血浆生物标志物与携带 APOL1 风险变异个体的肾脏结局相关。
Kidney Int. 2018 Jun;93(6):1409-1416. doi: 10.1016/j.kint.2018.01.026. Epub 2018 Apr 25.
9
Genotype and Renal Function of Black Living Donors.黑人活体供者的基因型与肾功能。
J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.
10
Apolipoprotein L1 Gene Effects on Kidney Transplantation.载脂蛋白 L1 基因对肾移植的影响。
Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006.
Zotero 插件